Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent Virus-like-particle (VLP) Influenza Vaccine in Adults
Phase of Trial: Phase I/II
Latest Information Update: 29 Sep 2015
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Medicago
- 24 Sep 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 04 Sep 2014 Planned primary completion date changed from 1 May 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
- 04 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.